Partnering with NeXell

Three routes to value, run in parallel. We advance our own solid-tumor pipeline while working with partners through co-development and licensing.

Programs Hitting a Specific Kind of Wall

Developers running into safety, durability or tumor-microenvironment limits in solid-tumor CAR programs. Developers of armored constructs and off-the-shelf products built on donor-derived cells.

A First Solid-Tumor Program, in Our Own Hands

We are advancing our first lead candidate for solid tumors, currently preclinical. Target, indication and timeline are shared under a mutual confidentiality agreement.